Research and Markets (http://www.researchandmarkets.com/research/brtzmp/neurofibromatoses)
has announced the addition of the "Neurofibromatoses
Type II - Pipeline Review, H2 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Neurofibromatoses Type II, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Neurofibromatoses Type II and special features on late-stage and
Drug profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
Reasons to buy
For more information visit http://www.researchandmarkets.com/research/brtzmp/neurofibromatoses
[ Back To NFVZone's Homepage ]